Cytokeratin 20-positive large cell neuroendocrine carcinoma of the colon

Pathology International

Volumn 55, Issue 8, 2005, Pages 524-529

  Kato, Tomoya ^a   Terashima, Toru ^a   Tomida, Shinji ^a   Yamaguchi, Takashi ^a   Kawamura, Hisao ^b   Kimura, Noriko ^c   Ohtani, Haruo ^a  

^a NATIONAL HOSPITAL ORGANIZATION MITO MEDICAL CENTER   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^c TOHOKU ROSAI HOSPITAL   (Japan)

Author keywords

Colon; Cytokeratin 20; Histogenesis; Large cell neuroendocrine carcinoma

Indexed keywords

CD56 ANTIGEN; CHROMOGRANIN A; CYTOKERATIN 20; SYNAPTOPHYSIN;

AGED; ANAMNESIS; ARTICLE; AUTOPSY; CANCER STAGING; CANCER SURGERY; CASE REPORT; CELL DIFFERENTIATION; CLINICAL FEATURE; COLON CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LIVER METASTASIS; MALE; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; RECURRENT DISEASE; SQUAMOUS CELL CARCINOMA; TUMOR CELL;

AGED; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; COLONIC NEOPLASMS; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; MICROSCOPY, ELECTRON;

EID: 23244435704     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2005.01864.x     Document Type: Article

References (20)

1. Gould VE, Chejfec G. Neuroendocrine carcinomas of the colon. Ultrastructural and biochemical evidence of their secretory function. Am J Surg Pathol 1978; 2: 31-8.
2. Bernick PE, Klimstra DS, Shia J et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum 2004; 47: 163-9.
3. Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press, 2000.
4. Travis WD, Linnoila RI, Tsokos MG et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol 1991; 15: 529-53.
5. Kende AI, Carr NJ, Sobin LH. Expression of cytokeratins 7 and 20 in carcinomas of the gastrointestinal tract. Histopathology 2003; 42: 137-40.
6. Moll R, Lowe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427-47.
7. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000; 13: 962-72.
8. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol 1995; 8: 384-8.
9. Kimura N, Pilichowska M, Date F, Kimura I, Schindler M. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors. Clin Cancer Res 1999; 5: 3483-7.
10. Mills SE, Allen MS Jr, Cohen AR. Small-cell undifferentiated carcinoma of the colon. A clinicopathological study of five cases and their association with colonic adenomas. Am J Surg Pathol 1983; 7: 643-51.
11. Gaffey MJ, Mills SE, Lack EE. Neuroendocrine carcinoma of the colon and rectum. A clinicopathological, ultrastructural, and immunohistochemical study of 24 cases. Am J Surg Pathol 1990; 14: 1010-23.
12. Staren ED, Gould VE, Warren WH et al. Neuroendocrine carcinomas of the colon and rectum: a clinicopathological evaluation. Surgery 1988; 104: 1080-89.
13. Vortmeyer AO, Lubensky IA, Merino MJ et al. Concordance of genetic alterations in poorly differentiated colorectal neuroendocrine carcinomas and associated adenocarcinomas. J Natl Cancer Inst 1997; 89: 1448-53.
14. Chan JKC, Suster S, Wenig BM, Tsang WYW, Chan JBK, Lau ALW. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 1997; 21: 226-34.
15. Cheuk W, Kwan MY, Suster S, Chan JKC. Immunostaining for thyroid transcription factor 1 and cytokeratin 20 aids the distinction of small cell carcinoma from merkel cell carcinoma, but not pulmonary from extrapulmonary small cell carcinomas. Arch Pathol Lab Med 2001; 125: 228-31.
16. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 2000; 24: 1217-23.
17. Cai YC, Banner B, Glickman J, Odze RD. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol 2001; 32: 1087-93.
18. Moldvay J, Jackel M, Bogos K et al. The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res 2004; 10: 85-8.
19. Moll R, Zimbelmann R, Goldschmidt MD et al. The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas. Differentiation 1993; 53: 75-93.
20. Sturm N, Rossi G, Lantuejoul S et al. Expression of thyroid transcription factor-1 in the spectrum of neuroendocrine cell lung proliferations with special interest in carcinoids. Hum Pathol 2002; 33: 175-82.